Is Indivior Pharmaceuticals, Inc halal to invest in?

As of July 2026, Indivior Pharmaceuticals, Inc INDV is classified as halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.

Is Indivior Pharmaceuticals, Inc a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Indivior Pharmaceuticals, Inc using these criteria to determine its compliance status.

Can Muslims buy shares of Indivior Pharmaceuticals, Inc?

Muslim investors may consider investing in Indivior Pharmaceuticals, Inc if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Indivior Pharmaceuticals, Inc classified as HALAL?

Musaffa determines the Shariah status of Indivior Pharmaceuticals, Inc by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Indivior Pharmaceuticals, Inc updated?

The Shariah compliance status of Indivior Pharmaceuticals, Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Indivior Pharmaceuticals, Inc become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Indivior Pharmaceuticals, Inc?

You can check the latest Shariah compliance status of Indivior Pharmaceuticals, Inc on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

INDV Shariah Compliance

Screening Methodology: AAOIFI

As of July 2026, Indivior Pharmaceuticals, Inc is classified as halal.

HALAL

Report Source: 2026 1st Quarter Report

Indivior Pharmaceuticals, Inc. Stock Analysis INDV

United States Health Care Mid Cap Report: Q1, 2026

Indivior Pharmaceuticals, Inc. is a specialty pharmaceutical company singularly focused on delivering evidence-based treatment and advancing understanding of opioid use disorder (OUD) as a chronic but treatable brain disease. The firm provides treatment for addiction, including SUBLOCADE (buprenorphine extended-release) injection for subcutaneous use, a long-acting injectable (LAI) for opioid use disorder and OPVEE (Nalmefene) nasal spray for opioid overdose recovery. Its core products include SUBOXONE Film, SUBOXONE Tablet, SUBUTEX Tablet, OPVEE (nalmefene), and SUBLOCADE. SUBOXONE Film is a buprenorphine and naloxone sublingual film. SUBOXONE Tablet is a buprenorphine and naloxone sublingual tablet. SUBUTEX Tablet is a buprenorphine sublingual tablet. SUBOXONE Film, SUBOXONE Tablet, SUBUTEX Tablet, and SUBLOCADE are treatments for opioid use disorder (OUD). In addition to its commercially available products, its product pipeline includes two drug candidates for the treatment of OUD. The company sells its products in the United States and in other selected areas of the world.

Key Statistics of Indivior Pharmaceuticals, Inc (INDV)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$39.87$40.57

Today's Open

$39.96

Volume

2.54M

P/E Ratio (TTM)

23.32

52 Week Range

$15.55$42.81

Market Cap

4.99B

Avg. Volume

1.84M

Dividend Yield

Financial Metrics & Statements of Indivior Pharmaceuticals, Inc (INDV)

Super Investors Invested in Indivior Pharmaceuticals, Inc (INDV)

FAQ's for Indivior Pharmaceuticals, Inc (INDV)

As of July 2026, Indivior Pharmaceuticals, Inc INDV is classified as halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Indivior Pharmaceuticals, Inc using these criteria to determine its compliance status.
Muslim investors may consider investing in Indivior Pharmaceuticals, Inc if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
Musaffa determines the Shariah status of Indivior Pharmaceuticals, Inc by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
The Shariah compliance status of Indivior Pharmaceuticals, Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.
Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
You can check the latest Shariah compliance status of Indivior Pharmaceuticals, Inc on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.